OBiO Know-how will showcase at American Society of Gene & Cell Remedy

-Go to OBiO Tech sales space #1644 at  American Society of Gene & Cell Remedy in Maryland, USA

SHANGHAI, April 28, 2024 /PRNewswire/ — OBiO Know-how (Shanghai) Corp., Ltd. (OBiO, 688238.SH), a world main contract improvement and manufacturing group for cell and gene remedy, will showcase at American Society of Gene & Cell Remedy in Maryland, USA from Might 7th to 11th. 9 posters can be offered at American Society of Gene & Cell Remedy.

Amongst these displays are three self-developed patented achievements, 4 notable developments in course of optimization, and two cutting-edge know-how introductions.

These milestones exemplify OBiO Know-how’s important strides within the gene remedy area, enhancing vector yield and effectivity, refining therapeutic processes, and driving down manufacturing prices.

The progressive options provided by OBiO Know-how present  reliable and cost-effective manufacturing strategies for gene remedy, propelling ahead scientific initiatives in gene and cell remedy.

OBiO Know-how’s consultants are able to share how their complete viral vector platform accelerates improvement timelines, de-risks manufacturing, and offers the efficiency and product high quality wanted to your success, with a decrease value.

“We’re delighted to proceed our legacy of excellence on the ASGCT convention! OBiO Know-how will take part with utmost enthusiasm and progressive prowess, showcasing our newest achievements in gene and cell remedy.” mentioned Javier Jia Guo, Ph.D., Chief Government Officer of OBiO Know-how. “Our 9 displays, that includes self-developed patented achievements, course of optimization breakthroughs, and know-how introductions, epitomize our dedication to relentless innovation and collaborative problem-solving. In addition they underscore our important progress in enhancing yield effectivity, streamlining manufacturing processes, and driving value efficiencies. OBiO Know-how stays steadfast in its forward-looking technological format and steady enchancment of service capabilities, contributing to the speedy development of the gene and cell remedy business.”

About OBiO Know-how

OBiO Know-how leads the best way in gene and cell remedy as a pioneering Contract Analysis Group (CRO) and Contract Improvement and Manufacturing Group (CDMO), devoted to offering complete options.

  • OBiO Know-how’s state-of-the-art 830,000 sq.ft facility ensures world provide excellence.
  • Specializing in vectorology research, practical genomics, and course of and analytics improvement, OBiO Know-how guarantee Investigational New Drug (IND) readiness and assist all phases of scientific and industrial manufacturing.
  • Guided by mission to “Allow Gene Remedy for Higher Lives,” OBiO Know-how prioritize delivering top-tier providers worldwide.
  • From laboratory to clinic, OBiO Know-how repeatedly advance your merchandise, making a optimistic affect on populations worldwide.
  • OBiO Know-how’s unwavering dedication ensures the supply of high-quality CDMO providers throughout the preclinical, IND, scientific, and industrial levels.
  • OBiO Know-how’s experience spans plasmids, mRNA, AAV, LVV, Advert viral vectors, cell remedy (CAR-T, NK, Treg), in addition to cutting-edge applied sciences like inducible viral vector packaging, ultralow endotoxin processes, and tissue-specific AAV variants.

SOURCE OBiO Know-how (Shanghai) Corp., Ltd.

Leave a Comment